Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APEACH: Apixaban in Early Liver Cirrhosis
NCT07726693Phase 3Not yet recruiting
- Sponsor
- University College London
- Start
- Jul 2026
- Primary completion
- Oct 2030
01
Overview
A Phase 3 trial of apixaban in Liver cirrhosis (LC), sponsored by University College London. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
apixaban
03
Conditions
Liver cirrhosis (LC)
Beyond the preview
Go deeper on NCT07726693.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07726693.